Clinical Trials Directory

Trials / Unknown

UnknownNCT06347783

Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes

The Effect of Automated Insulin Delivery on Sleep Compared to Multiple Daily Injections in Pediatric Patients With Type 1 Diabetes

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to learn about the effect of insulin pumps on sleep in pediatric patients with type 1 diabetes and their caregivers. We are hoping to find out if insulin pumps improve sleep, worsen sleep, or have no effect at all. We are hoping to also explore the relationship between insulin pumps, sleep, and overnight blood sugar control. Your information will not be stored and used for future research. The goal of this observational study is learn about the effect of insulin pumps on sleep in pediatric patients with type 1 diabetes and their caregivers. The main questions it aims to answer are: Do insulin pumps improve sleep, worsen sleep or have no effect at all? What is the relationship between insulin pumps, sleep, and overnight blood sugar control? Participants will be asked to: * Complete questionnaires regarding demographic data and diabetes history. * Complete surveys regarding sleep quality before and after starting an insulin pump. * Wear a FitBit during sleep for 2 weeks and fill out daily sleep diaries over a 2 week period prior to starting an insulin pump. After 1-2 months after initiation of an insulin pump, participants will be asked again to: * Complete surveys regarding sleep quality * Wear a FitBit during sleep for 2 weeks * Fill out daily sleep diaries over the same 2 week period.

Conditions

Interventions

TypeNameDescription
DEVICEInsulin pumpContinuous subcutaneous insulin therapy.

Timeline

Start date
2024-05-15
Primary completion
2024-11-15
Completion
2024-12-15
First posted
2024-04-04
Last updated
2024-04-04

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06347783. Inclusion in this directory is not an endorsement.